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Abstract Our previous data suggested that angiopoietin-
2 (Ang-2) is linked to pericyte loss, thereby playing an
important role in diabetic retinopathy. In this study, we
investigated the effect of retinal overexpression of human
Ang-2 (mOpsinhAng2 mouse) on vascular morphology in
non-diabetic and streptozotozin-induced diabetic animals.
Pericyte (PC) coverage and acellular capillary (AC) for-
mation were quantitated in retinal digest preparations after
3 and 6 months of diabetes duration. The degree of reti-
nopathy in non-diabetic mOpsinhAng2 mice at 3 months
(-21% PC, ?49% AC) was comparable to age-matched
diabetic wild type mice. Diabetic mOpsinhAng2 mice
exhibited significantly worse vascular pathology than wild
type counterparts at 6 months. Quantitative PCR revealed
that human Ang-2 mRNA was highly overexpressed in
retinas of transgenic mice. Our data demonstrate that
overexpression of Ang-2 in the retina enhances vascular
pathology, indicating that Ang-2 plays an essential role in
diabetic vasoregression via destabilization of pericytes.
Keywords Angiopoietin-2  Diabetic retinopathy 
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Introduction
Diabetic retinopathy (DR) is a common microangiopathy
in diabetes. Hyperglycemia, the central initiating factor in
DR, induces pathological changes in the retinal vascular
bed, even early when the retina is clinically unaffected.
Pericytes with glial cells enveloping capillaries are
important for the protection of endothelial cells against
damages from the harmful environment within the retina.
In DR, hyperglycemia results in loss of pericytes, followed
by degeneration of endothelial cells and capillary occlu-
sions [2, 11, 13]. Enge et al. [3] demonstrated the
association of reduced pericyte coverage with retinopathy
in a transgenic mouse model with conditional inactivation
of the pericyte recruiting factor PDGF-B. They found that a
50% reduction of pericytes is the threshold for the devel-
opment of vascular proliferation, indicating the crucial role
of pericytes in the maintenance of vascular integrity and
normal function.
There is emerging evidence indicating that factors, such
as the angiopoietin-Tie2 system are involved in hypergly-
cemia-induced pericyte loss and the progression of DR.
Angiopoietin-2 (Ang-2) is an important molecule involved
in the adherence of pericytes to the capillaries ensuring the
maturation, integrity and physiological functions of the
vasculature [5, 7, 9]. Increasing evidence suggests that
Ang-2 plays an important role both in physiological and in
pathological angiogenesis, as well as in diabetic retinopa-
thy [6–8, 12, 15]. Our previous data have demonstrated that
Ang-2 is upregulated prior to morphological changes of
retinal capillaries in diabetic retinopathy. Administration of
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Ang-2 into adult eyes results in pericyte loss. Reduction of
Ang-2 in the Ang2LacZ murine retina protects capillaries
from pericyte loss and decreases the numbers of acellular
capillaries (ACs) in experimental diabetic retinopathy [8].
Moreover, we assessed pericyte coverage under overex-
pression of Ang-2 in the retinal development using a
transgenic mouse line with overexpression of human Ang-2
under the mouse opsin promoter in the photoreceptor cells
(mOpsinhAng2 mouse). We found reduced pericyte cov-
erage and accelerated retinal vascular development in
physiological and pathological angiogenesis in the retina
demonstrating the effect of Ang-2 on capillary formation in
the development [4]. However, the further fate of retinal
capillaries in this gain-of-function model is unknown,
Diabetes causes Ang-2 upregulation predominantly in
the ganglion cell layer and inner nuclear cell layer in the
retina [12]. Endothelial and glial upregulation of Ang-2 has
been evidenced [1, 10, 16]. By combining constitutive and
hyperglycemia-inducible Ang-2 overexpression in the
diabetic mOpsinhAng2 mice, we aimed to assess the
functional consequences on retinal vessels.
Materials and methods
Animals
The care and experimental use of all animals in this study
were in accordance with institutional guidelines and in
compliance with the Association for Research in Vision
and Ophthamology (ARVO) statement. The transgenic
mOpsinhAng2 mouse was identified by genotyping as
described previously [4].
Diabetes induction
Eight-week-old heterozygous mOpsinhAng2 mice and
their wild type littermates were randomly divided into a
non-diabetic and a diabetic group. The mice of the diabetic
group were injected intraperitoneally with streptozotozin
(STZ, 150 mg/kg body weight) diluted in citrate buffer (pH
4.5). STZ was purchased from Sigma, Germany. Diabetes
was considered successfully induced as blood glucose
levels were stable over 250 mg/dl. Blood glucose levels
and body weight were monitored regularly and HbA1c was
measured when the mice were sacrificed at 3 and 6 months
after induction of diabetes. Eyes were immediately frozen
at -80C until further analysis.
RNA isolation and quantitative PCR
Retinal RNA was isolated from individual retinas homoge-
nized in 1 ml Trizol reagent (Invitrogen, Karlsruhe, Germany)
at 4C according to the manufacturer’s instructions. Then,
RNA was reverse transcribed with QuantiTect Reverse
Transcription kit (Qiagen GmbH, Germany) and subjected to
Taqman analysis using the Taqman 2 9 PCR master Mix
(Applied Biosystems, Weiterstadt, Germany). The expression
of genes was analysed by the 2-DDCT method using 18s
ribosomal RNA as housekeeping control. All primers were
designed according to the specific sequences in the Genbank
and purchased from IBA (Göttingen, Germany) and primers
and FAM-labeled Taqman TAMRA probes used were: S18:
forward 50-ACC ACA TCC AAG GAA GGC AG-30, reverse
50-TTT TCG TCA CTA CCT CCC C-30, probe 50-AGG CGC
GCA AAT TAC CCA CTC CC-30; VEGF: forward 50-CGA
GAT AGA GTA CAT CTT CAA GCC G-30, reverse 50-TCA
TCG TTA CAG CAG CCT GC-30, probe 50-CTG TGT GCC
GCT GAT GCG CTG-30; Ang-1: forward 50-CAA CAA CAG
CAT CCT GCA GAA-30, reverse 50-CTT TAG TGC AAA
GGC TGA TAA GGT T-30, probe 50-CAA CAA CTG GAG
CTC ATG GAC ACA GTT CA-30; mAng2: forward 50-TGC
GGA AAT CTT CAA GTC AGG-30, reverse 50-CCT TGA
TCT CCT CTG TGG AGT TG-30, probe 50-CAC CAG TGG
CAT CTA CAC ACT GAC CTT CC-30; hAng2: forward
50-TCC TCC TGC CAG AGA TGG AC-30, reverse 50-TGC
ACA GCA TTG GAC ACG TA-30, probe 50-ACT GCC GCT
CTT CCT CCA GCC C-30; Tie2: forward 50-ACA TAG GAG
GAA ACC TGT TCA CCT-30, reverse 50-CCC CCA CTT
CTG AGC TTC AC-30, probe 50-AGC CTT CAC CAG GCT
GAT TGT TCG G-30.
Retinal digest preparation
Retinas of mOpsinhAng2 mice were fixed in 4% parafor-
maldehyde for 24–48 h. Then, retinas were incubated in
aqua bidest for 30 min. Subsequently, the retinas were
transferred to a 3% trypsin solution resolved in 0.2 M Tris
buffer, pH 7.4, for 2–3 h. The retinas of mOpsinhAng2
mice were washed with aqua bidest, and isolated retinal
vasculature was flat mounted on objective slides. For
quantification of pericyte numbers, the samples were
stained with periodic acid Schiff base and hematoxylin
(PASH). During digestion, vitreous with inner limiting
membrane were carefully moved away.
Quantitative retinal morphometry
Analysis of pericyte coverage of the retinal vasculature was
carried out in the retinal digest preparations stained with
PASH as described previously [8]. In brief, the total
numbers of pericytes were counted in ten randomly
selected fields of the retina using an image analyzing sys-
tem (CUE-2; Olympus Opticals, Hamburg, Germany), and
their numbers were normalized to the relative capillary
density (numbers of cells per mm2 of capillary area). The
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numbers of ACs were counted according to an established
method in ten randomly selected fields as described pre-
viously [8]. Samples were evaluated in a masked fashion.
Statistic analysis
Data are expressed as mean ± SD. Data analysis was
performed by using ANOVA and a p \ 0.05 was consid-
ered as statistical significance.
Results
Overexpression of Ang-2 in the retina does not change
metabolic parameters in experimental diabetic
retinopathy
At 6 months, non-diabetic mOpsinhAng2 mice showed
normal blood glucose levels and similar body weight com-
pared to the non-diabetic wild type mice. Blood glucose was
178 ± 23 mg/dl in non-diabetic mOpsinhAng2 mice and
164 ± 18 mg/dl in non-diabetic wild type mice, while body
weight was 35 ± 5 g in non-diabetic mOpsinhAng2 mice
and 36 ± 5 g in non-diabetic wild type mice. Overexpres-
sion of Ang-2 did not change HbA1c values in transgenic
mice (mOpsinhAng2 5.4 ± 0.9% vs. wild type 5.2 ± 1.1%).
As in wild type animals, streptozotozin injection induced
significantly hyperglycemia, body weight loss and elevated
HbA1c in mOpsinhAng2 mice. Diabetic mOpsinhAng2
mice had blood glucose levels comparable to diabetic
wild type mice (diabetic mOpsinhAng2: 587 ± 33 mg/dl,
diabetic wild type mice: 593 ± 17 mg/dl). Body weight of
23 ± 5 g in diabetic mOpsinhAng2 mice was similar to
25 ± 3 g in diabetic wild type mice. Elevated HbA1c did not
differ significantly in diabetic mOpsinhAng2 and diabetic
wild type mice.
Overexpression of Ang-2 in the retina mimics DR
and aggravates vascular damages in experimental
diabetic retinopathy
To assess the relationship between retinal overexpression of
Ang-2 and pericyte coverage in hyperglycemia, we analysed
pericyte coverage of heterozygous mOpsinhAng2 retinas
after 3- and 6-month of hyperglycemia using retinal digest
preparations. Overexpression of Ang-2 in the non-diabetic
retina led to significant pericyte dropout of about 21%
compared to the non-diabetic wild type retina at 3 and
6 months (1,705 ± 155/mm2 of capillary area in non-
diabetic mOpsinhAng2 mice vs. 2,161 ± 144/mm2 of cap-
illary area in non-diabetic wild type mice at 3 months,
1,720 ± 68/mm2 of capillary area in non-diabetic mOp-
sinhAng2 mice vs. 2,151 ± 109/mm2 of capillary area in
non-diabetic wild type mice at 6 months, respectively.
Fig. 1 Vascular morphological
demonstration of diabetic
mOpsinhAng2 retinas.
Representative demonstration
(a–d) of retinal vascular
morphology in retinal digest
preparations. a, b wild type
mice; c, d mOpsinhAng2 mice;
a, c 6 months non-diabetic
mice; b, d 6 months diabetic
mice. Arrows: acellular
capillaries. Magnifications:
4009
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Figs. 1, 2). A significant decrease of pericyte numbers was
observed in diabetic wild type mice at 3 and 6 months
(p \ 0.01 and p \ 0.001 vs. non-diabetic wild type mice,
respectively). Pericyte reduction in non-diabetic mOpsin-
hAng2 mice at 3 and 6 months were similar to the reduced
pericyte numbers of age-matched diabetic wild type mice.
Hyperglycemia had no influence on pericyte numbers at
3 months in mOpsinhAng2 mice (p [ 0.05), but diabetes in
mOpsinhAng2 mice led to more pericyte loss in the retina at
6 months (1,355 ± 226/mm2 of capillary area in diabetic
mOpsinhAng2 mice and 1,671 ± 220/mm2 of capillary area
in diabetic wild type mice, Figs. 1, 2, p \ 0.001).
Consequently, diabetes-induced formation of ACs was
determined in the retinas of mOpsinhAng2 mice. Hyper-
glycemia increased the formation of ACs in wild type mice
after 6 months of diabetes duration, as demonstrated in
Figs. 1 and 3. At 3 months, overexpression of Ang-2 in the
retina caused increased ACs in non-diabetic animals
(29 ± 5 AC/mm2 of retinal area in non-diabetic mOpsin-
hAng2 mice vs. 20 ± 5 AC/mm2 of retinal area non-
diabetic wild type mice), similar to increased ACs in dia-
betic wild type mice (27 ± 6 AC/mm2 of retinal area). At
6 months, formation of ACs remained elevated in non-
diabetic mOpsinhAng2 mice. Diabetes shifted the forma-
tion of ACs in transgenic mice in similar extent to diabetic
wild type mice and thereby onto the highest level among
the age-matched groups (40 ± 7 AC/mm2 of retinal area in
diabetic mOpsinhAng2 vs. 29 ± 5 AC/mm2 of retinal area
in non-diabetic mOpsinhAng2 mice at 3 months,
65 ± 6 AC/mm2 of retinal area in diabetic mOpsinhAng2
vs. 33 ± 5 AC/mm2 of retinal area in non-diabetic mOp-
sinhAng2 mice at 6 months). No retinal vascular
abnormalities such as microaneurysms and dilatation of
vessels were observed in retinal digest preparations of
mOpsinhAng2 mice (data not shown).
Human Ang-2 is highly overexpressed in transgenic
retinas
Variation in gene expression precedes vascular morpho-
logical changes in the 3- and 6- month retinas; therefore,
we performed quantitative real time PCR using 3-week
retinas to identify the gene expression of endogenous Ang-
2, Ang-1 Tie2 and VEGF, and transgenic human Ang-2.
Human Ang-2 was strongly overexpressed in transgenic
retinas, whereas it was not detectable in retinas of wild type
mice. Retinal overexpression of human Ang-2 in non-dia-
betic transgenic animals did not affect the expression of
endogenous Ang-1, mouse Ang-2 and their receptor Tie2
compared to non-diabetic wild type mice. Morover, 3-week
hyperglycemia, both in transgenic and non-transgenic
animals did not alter the expression of Ang-1, mouse and
human Ang-2 and their receptor Tie2 compared to their
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Fig. 2 Pericyte coverage of diabetic mOpsinhAng2 retinas. Pericyte
coverage was quantitatively analysed in retinal digest preparations.
Opsin: mOpsinhAng2, and WT: wild type mice in diabetic (filled
square) and non-diabetic (open square) mice at 3 and 6 months after
diabetes induction. n = 6. Data are means ± SD. *p \ 0.05,
**p \ 0.01, ***p \ 0.001
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Fig. 3 Formation of acellular capillaries of diabetic mOpsinhAng2
retinas. Segments of acellular capillaries were quantitatively analysed
in retinal digest preparations. Opsin: mOpsinhAng2, and WT: wild
type mice in diabetic (filled square) and non-diabetic (open square)
mice at 3 and 6 months after diabetes induction. n = 6. Data are
mean ± SD. *p \ 0.05, **p \ 0.01, ***p \ 0.001
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non-diabetic controls (Fig. 4). Modulation of VEGF
expression was observed neither in transgenic mOpsin-
hAng2 retinas compared with their non-transgenic animals,
nor in 3-week hyperglycemic non-transgenic and trans-
genic retinas compared with their non-diabetic controls
(data not shown).
Discussion
Our study demonstrates that constitutive overexpression of
Ang-2 in the retinal photoreceptor cells induces vascular
pathology, mimicking diabetic retinopathy. Furthermore,
we show that constitutive overexpression of Ang-2
enhances further vascular damages in hyperglycemia.
Retinal vasoregression is characteristic for DR. We
observed that overexpression of Ang-2 in retinal neurons
leads to pericyte loss and AC formation in the normo-
glycemic retina. The retinal vascular changes of normo-
glycemic mOpsinhAng2 mice resemble qualitatively and
quantitatively those observed in 3 month diabetic wild type
mice. Together with our previous data showing pericyte
loss is linked to augmented Ang-2 from vitreous and glia
[8], the data in present study reinforce the importance of
Ang-2 in controlling pericyte coverage of mature retinal
vessels and its crucial role in the development of DR.
Compared with development of pericyte loss in diabetic
wild type mice, hyperglycemia did not result in a further
extent of pericyte loss in diabetic mOpsinhAng2 retinas at
3 months. The lack of progression in pericyte loss in dia-
betic mOpsinhAng2 retinas suggests that there might be a
temporal validity of Ang-2 or a threshold for pericyte loss
in mOpsinhAng2 retinas. Enge et al. [3] found a 50%
reduction of PCs is the threshold for the development of
proliferative DR correlated with PDGF-B. Similarly, we
found that there likely is a threshold level of approximately
20% pericyte loss for Ang-2 dependent vasoregression.
Nevertheless, this threshold was broken by long-term
hyperglycemia of 6 months. In the combined model,
hyperglycemia induces an additional release of Ang-2 from
glial cells, explaining the further increase of pericyte loss
and vasoregression in diabetic mOpsinhAng2 mice at
6 months. Other hyperglycemia-induced factors within the
retina, which additively promote retinal vasoregression
could participate in the further increase of retinal pericyte
loss and AC formation in diabetic mOpsinhAng2 retinas.
In the normal retina, Ang-2 is expressed in neuronal
cells and in some undefined cell types of the ganglion cell
layer [6]. In the diabetic retina, endothelial cells and glial
cells might be the main sources of Ang-2 [1, 10, 16]. An
increase of Ang-2 expression has been described in the
inner nuclear layer after 6 months of hyperglycemia [12].
However, the precise mechanisms underlying Ang-2
upregulation in the diabetic retina remain to be elucidated.
Recently, Yao et al. [16] reported that hyperglycemia
induces intracellular formation of methylglyoxal which
activates Ang-2 transcription through modification of
mSin3A. In a parallel experiment using the same mOp-
sinhAng2 mice, we showed that overexpression of Ang-2
results in elevated pericyte migration in certain pericyte
subpopulations, indicating a novel mechanism for pericyte
loss in DR [14]. In the present study, we quantitatively
demonstrate that overexpression of Ang-2 results in sig-
nificant pericyte loss and formation of ACs comparable to
diabetic wild type mice. Thus, mOpsinhAng2 mouse pre-
sents a suitable mouse model for elucidating mechanisms
involved in retinal vasoregression related to elevated Ang-
2 levels. In the present study, we did not observe an
increase in RNA expression of Ang-2 in diabetic wild type
mice in contrast to what we reported before in the rat [8].
Species difference may be one explanation, and the other
could be the early time point studied (3 weeks), as vascular
damage in the mouse retina is generally milder than in the
rat. In comparison with our previous observation, a *20%
decrease of pericyte coverage in diabetic mouse retina at
6 months has been revealed in diabetic rat retina at
3 months after diabetes induction [8]. In this study, we
provide evidence that human Ang-2 is highly expressed in
transgenic retinas, resulting in earlier vascular pathology in
the retina.
In conclusion, our study provides evidence that Ang-2
plays a critical role in retinal vascular maintenance and in
retinal vascular damage of early diabetic retinopathy.
These data contribute to the understanding of Ang-2
function in retinal vasoregression and thus are important
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Fig. 4 Expression of Ang-1, mouse and human Ang-2, and Tie2 in
diabetic mOpsinhAng2 retinas at 3 weeks after diabetes induction. N
non-diabetic, D diabetic, Opsin mOpsinhAng2 mice, WT wild type
mice. mAng2 mouse angiopoietin-2, hAng2 human angiopoietin-2.
n = 5–9. Expression of Ang-1 in non-diabetic wild type is set as 100
because of logarithmic scales on the y axis. Data are mean ± SD
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for development of therapeutic interventions to prevent
diabetic retinopathy.
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